U.S. Pharma Stock News

Wondering if Stanley Black & Decker at around US$72 is a bargain or just fairly priced? This article walks through what the current share price might be telling you about value. The stock has returned 5.2% over the last 7 days, is down 2.1% over 30 days and 5.6% year to date, while still sitting on a 28.2% return over the past year and 2.5% over three years, compared with a 58.2% decline across five years. Recent coverage has focused on how the share price performance compares with longer...

Wondering whether Lantheus Holdings at around US$80.59 is offering value right now, or if the best days are already priced in? This article is designed to help you answer that question with a clear valuation focus. The stock has had a mixed run, with a 5.9% gain over the last 7 days, a 2.5% decline over the past month, a 19.8% gain year to date, and a 21.0% decline over the last year, which may hint at shifting views on its risk and potential. Recent coverage has highlighted Lantheus...

BigBear.ai Holdings (NYSE:BBAI) is shifting focus from government services toward a platform-centric AI model built around the Ask Sage generative AI acquisition. The company has also completed a major balance sheet recapitalization, improving liquidity to support this repositioning. These moves come as BigBear.ai continues to face revenue pressures and execution risks while pursuing an active M&A pipeline. BigBear.ai Holdings, trading at around $3.32, has had a mixed share price track...

WD-40 (WDFC) has just posted Q2 2026 revenue of US$161.7 million. Investors looking at the broader picture will see trailing 12 month revenue at about US$636.5 million and basic EPS of US$6.59 paired with net income of US$89.3 million. The company has seen quarterly revenue move from US$146.1 million in Q2 2025 to US$161.7 million in Q2 2026, with basic EPS across recent quarters ranging from about US$1.29 to US$2.20. This sets up the latest print as part of a steady, margin conscious story...

Lotus Technology (NasdaqGS:LOT) has just posted its FY 2025 third quarter numbers, with revenue of US$137.4 million, a net loss of US$65.4 million and basic EPS of a US$0.10 loss. The trailing twelve months show revenue of US$627.3 million and a net loss of US$818.3 million, or EPS of a US$1.24 loss. Over recent quarters the company has reported revenue moving from US$271.5 million in FY 2024 Q4 to US$92.8 million in FY 2025 Q1, then to US$125.5 million in Q2 and US$137.4 million in Q3...

Simulations Plus (SLP) has put up a mixed Q2 2026 scorecard, with revenue of about US$24.3 million and basic EPS of roughly US$0.22, alongside trailing twelve month figures that show total revenue of about US$80.5 million and a basic EPS loss of roughly US$3.12. Over recent quarters, revenue has ranged from about US$17.5 million to US$24.3 million while quarterly basic EPS has swung between a loss of about US$3.35 and a profit of roughly US$0.22. This leaves investors focused squarely on how...

HEICO (NYSE:HEI) has agreed for its Flight Support Group to acquire 80% of Sherwood Avionics and Accessories. HEICO’s Electronic Technologies Group has agreed to acquire 90% of Southwest Antennas, a supplier of rugged RF and microwave antennas. Both transactions are expected to be immediately accretive to earnings and to expand HEICO’s reach in aerospace repair, defense and communications solutions. For investors following NYSE:HEI, these transactions add fresh detail to how the company...

Neogen (NEOG) has just posted Q3 2026 results with revenue of US$211.2 million and a basic EPS loss of US$0.08, alongside trailing twelve month revenue of US$870.6 million and a basic EPS loss of US$2.80. This keeps the focus firmly on how efficiently the business is converting sales into earnings. Over recent quarters the company has seen revenue move from US$231.3 million in Q2 2025 to US$225.5 million in Q4 2025, then to US$209.2 million in Q1 2026 and US$224.7 million in Q2 2026 before...

Cactus, Inc. announced that director Bruce Rothstein informed the company he would not stand for re-election at the 2026 Annual Meeting, prompting the board to reduce its size to eight members effective immediately before that meeting. The orderly board reshaping, with no disagreements cited over operations or policies, highlights Cactus’s emphasis on continuity in governance while it executes its broader growth plans. With this orderly board transition underway, we’ll explore how Cactus’s...

Tapestry (NYSE:TPR) has appointed Matt Madrigal, Chief Technology Officer of Pinterest, to its Board of Directors. Madrigal brings experience from Pinterest, Google, Fanatics, and Williams Sonoma across product, technology, and e commerce. The appointment adds deeper expertise in digital strategy and Gen Z consumer behavior to Tapestry's leadership. Tapestry, trading at $152.62, has seen very strong share price performance, with the stock up 8.1% over the past week and 18.2% year to date...

Investors may be wondering whether GigaCloud Technology at US$46.50 is still offering value after its strong run, or if the easy gains are already behind it. The stock has recently posted returns of 3.8% over 7 days, 8.9% over 30 days, 20.0% year to date and 301.6% over the past year. This naturally raises questions about how the current price lines up with underlying value and risk. Recent headlines around GigaCloud Technology have focused on its role in the retail distribution space and...

Wondering if Marriott Vacations Worldwide at around US$68.50 is offering value or just looks cheap on the surface? This article walks through what the current price might really mean for you. The stock has returned 1.6% over the last 7 days, 2.9% over the last 30 days, 16.4% year to date and 36.0% over the last year, but those gains sit alongside a 43.1% decline over 3 years and a 54.7% decline over 5 years. These mixed returns have put more attention on what is driving sentiment around the...

If you are wondering whether Antero Midstream’s share price still offers value at around US$22.21, you are not alone, many investors are asking the same question right now. The stock has had a mixed recent run, with a 2.4% decline over the last week and a 1.7% decline over the last month, yet it is still up 23.8% year to date and 47.2% over the past year. Those moves have put valuation under the spotlight again, as investors weigh up Antero Midstream’s role within the broader energy...

Millrose Properties (MRP) has moved into focus after Greenhaven Associates fully exited its 4,596,584 share position and the company amended its credit facility with JPMorgan, adding a new $500 million unsecured term loan. See our latest analysis for Millrose Properties. The recent credit facility amendment and Greenhaven exit come after a mixed stretch for the stock, with a 1-day share price return of 3.74% and a 7-day share price return of 8.29%, while the 1-year total shareholder return...

Science Applications International (NasdaqGS:SAIC) has added Paul Eremenko and retired Navy Admiral Michael Rogers to its Board of Directors. Eremenko brings a background in AI and advanced technology integration, while Rogers adds experience from senior cybersecurity and intelligence roles. The appointments expand board expertise in areas that are central to SAIC's work with defense, federal, and technology focused customers. Science Applications International, traded as NasdaqGS:SAIC, is...

American Healthcare REIT, Inc. has already amended its primary credit facility and launched a US$1.75 billion at-the-market equity program, extending revolving loan maturities to April 1, 2030 and increasing borrowing flexibility under tighter leverage and coverage covenants. This combination of longer-dated debt capacity and flexible equity issuance reshapes the REIT’s funding toolkit, potentially affecting how it balances growth, balance sheet strength and future portfolio decisions. Next,...

Amylyx Pharmaceuticals recently saw increased analyst attention after the FDA approved its lead therapy AMX0035 for amyotrophic lateral sclerosis, reinforcing its focus on rare neurological diseases. This wave of analyst optimism underscores how regulatory progress on AMX0035 may influence expectations for Amylyx’s broader pipeline and long-term business potential. We’ll now explore how this renewed analyst confidence following AMX0035’s FDA approval could influence Amylyx Pharmaceuticals’...

The United States market has experienced a robust performance, climbing 3.4% in the last week and 30% over the past year, with earnings projected to grow by 16% annually. In such an environment, identifying stocks that may be undervalued can provide investors with opportunities to potentially capitalize on intrinsic value estimates that suggest significant upside potential.

The United States market has shown robust performance, climbing 3.4% in the last 7 days and rising 30% over the past year, with earnings projected to grow by 16% annually in the coming years. In such an environment, growth companies with high insider ownership often attract attention as they may signal strong confidence from those closest to the business's operations and future prospects.

The market has climbed 3.4% in the last 7 days and an impressive 30% over the past year, with earnings projected to grow annually by 16%. In light of these robust market conditions, identifying stocks with strong financials becomes crucial for investors looking to capitalize on growth opportunities. Although often considered a relic, penny stocks still hold potential when backed by solid fundamentals, offering a unique blend of value and growth that might not be found in larger companies.

The United States market has shown robust performance, rising 3.4% over the last week and climbing 30% in the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying stocks that are not only underappreciated but also poised to capitalize on these favorable conditions can be particularly rewarding for investors seeking unique opportunities.

The market has climbed 3.4% in the last 7 days and is up 30% over the last 12 months, with earnings expected to grow by 16% per annum over the next few years. In such a robust environment, reliable dividend stocks can offer a steady income stream while potentially benefiting from overall market gains.

Wondering whether Symbotic at around US$53.59 is priced for its future potential or already running ahead of itself? This breakdown will help you assess what you are really paying for. The stock has returned 0.4% over the last week and 7.4% over the last month, while year to date it is down 17.4% after a 167.7% return over the past year and a 96.5% return over three years. Recent headlines have focused on Symbotic's role in warehouse automation and its partnerships with large retailers...

For investors wondering whether Carlisle Companies at around US$350 a share still offers value, or if most of the upside is already priced in, this article walks through what the current market price may be implying. The stock has recently shown mixed momentum, with a 5.8% gain over the last week, a 0.7% decline over the last month, and returns of 6.7% year to date and 5.4% over the past year. Over a longer stretch, Carlisle Companies has delivered returns of 71.9% over 3 years and 115.3%...